In 2007, nearly 40,000 HFMD cases were reported in Shandong and over 10,000 cases were recorded in large cities such as Beijing and Shanghai [41]
In 2007, nearly 40,000 HFMD cases were reported in Shandong and over 10,000 cases were recorded in large cities such as Beijing and Shanghai [41]. for these age groups. Conclusions All the above findings indicated common infections for these age groups. And they should clearly become at the top of the priority in periodical seroprevalence survey and long term vaccination marketing campaign. Keywords: Enterovirus 71, Coxsackievirus A 16, Seroprevalence Background Hand, foot and mouth disease (HFMD) is definitely a common pediatric illness [1]. It is characterized by 3C4 days of fever and then the development of vesicles within the palmar and plantar pores and skin, buccal mucosa and tongue [2-4]. This illness as itself is definitely slight and self-limited [5]. While in some cases, accompanied with additional neurological complications, HFMD may also lead to severe results and even death [6-8]. Children under 10 years old especially those less than 5 are the most vulnerable population for reasons that are not NVP-BSK805 clearly recognized [2,9-11]. The 1st viral agent recognized for HFMD is definitely Coxsackievirus A 16 (CA16) [12]. Belonging to the picornaviridae family, this virus, associated with Enterovirus 71 (EV71), is responsible for nearly all of the HFMD epidemics in Southeast Asia [13,14]. In Japan, CA16 was reported to be a common type, while EV71 recurrent every 3 years [10,15]. In Singapore, from 2001 to 2008, the predominant EV strains isolated from HFMD instances were CA16 and EV71 [16,17]. In China, EV71 and CA 16 will also be regularly reported to co-circulate and cause HFMD, although the major etiologic agent recognized from hospitalized instances was EV71 [18,19]. Many large HFMD outbreaks with severe and fatal results in Southeast Asia have recently been explained [4,20]. In Taiwan, the most severe HFMD outbreak occurred in 1998, resulting in 405 severe neurological instances and 78 deaths [21,22]. In China, the recent outbreaks of HFMD were initiated from 2007 in Shandong province. Then a national common epidemic occurred in 2008, with more than 176,000 reported human being cases [23]. Contrary to HFMD outbreaks in additional Asian countries, the epidemics in China were more enduring [24]. Unprecedented HFMD outbreaks occurred in the following years. By the end of 2010, a total of 3,419,149 instances and 1384 fatal instances were reported [25,26]. It is said that the recently occurred HFMD epidemics have become a serious general public health problem in Southeast Asia, especially in China. Currently,only a few studies have been carried out to investigate the human being immunity to HFMD in China [27,28]. The seroepidemiology of EV71 illness before, during and shortly after the epidemics could pave ways for prophylactic treatment strategies. In addition, several EV71 vaccine candidates are being developed in mainland China from 2008 [29-31]. And some of them are at NVP-BSK805 various stages of clinical development [32,33]. To better establishing the immunization program against EV71 and CA16 contamination, seroepidemiological surveillance is usually urgently needed. In this study, we conducted a cohort study in Guangdong province, China. Children less than 10 years old were enrolled. The levels of EV71 and CA16 specific antibodies in children aged between 1 and 9 years were evaluated and compared for 3 years (2007C2009). Methods Serum samples collection The material used in this study is stored NVP-BSK805 serum samples collected from the health children 9 years of age who experienced participated in seasonal immune status surveillance at Guangdong Provincial Centre for Disease Control and Prevention, China, from 2007 to 2009. Survey questionnaire was completed by trained interviewers and included information around the subjects age, gender, vaccination history (over the past 12 months) and presence/absence of illnesses (over the past year). All children experienced no sign of disease at the time of sample collection. The serum samples were stored at ?80C until screening. For the use of these serum samples, written informed consents from all participants (their parents or legal guardians) involved in survey were obtained. Serum samples from children who reported fever and vesicular exanthema on their hands, feet, mouths, or buttocks (unique MYLK clinical presentation of HFMD) over the past year were excluded in this study and were classified into seven age groups (1, 2, 3, 4, 5, 6C7 and 8C9 years). Each group has 35C40 samples, except age group 1, 2 years in 2007(3 in 1 year group, 24 in 2 12 months group) and 8C9 years group in 2008 and 2009 (24 and 23 samples respectively). The sex ratios of males to girls were 1.36:1, 1.43:1, and NVP-BSK805 1.25:1 respectively. The demographic profile of the subjects is shown in Table?1. The.